For-profit organizations · Edmonton, Alberta
Entos Pharmaceuticals Inc.
- Total value
- $88.8M
- Agreements
- 14
- Programs
- 3
- First and latest
- 2016–2025
Federal grants and contributions, agreements starting Jan 2006 to Oct 2026, each counted once at its latest amended value. Source: Treasury Board proactive disclosure, published October 11, 2026. Agreements under programs that mostly fund individuals are not listed under any name.
See this recipient’s records on the government’s search
Applying for the same funding? SIF — Business Innovation and Growth projects (no intake dates on the official page); NRC IRAP Financial Assistance (apply through the funder’s page; no deadline stated); Trade Commissioner Service — Canadian International Innovation Program (CIIP) Co-innovation projects (intake periods; dates not on the page). Deadlines, who can apply and who else got it.
By program
| Program | Department | Agreements | Total |
|---|---|---|---|
| SIF Stream2- Growth | Innovation, Science and Economic Development Canada | 1 | $62M |
| Industrial Research Assistance Program – Contributions to Firms | National Research Council Canada | 9 | $26.6M |
| Canadian International Innovation Program (CIIP) | Global Affairs Canada | 1 | $7,802 |
Plus 3 agreements ($150K) where the department did not name a program.
Agreements
Newest first.
| Start | Program | What for | Value |
|---|---|---|---|
| Nov 2025 | Industrial Research Assistance Program – Contributions to FirmsNational Research Council Canada | Development of an Inhaled Genetic Medicine for Pre-Exposure Prophylaxis of H5N1 InfluenzaContribution | $764,000 |
| Aug 2025 | Industrial Research Assistance Program – Contributions to FirmsNational Research Council Canada | UK Biomanufacturing - 10143578 - NPmsDNA2024 - Development of in vivo targeted non-viral gene therapiesContribution | $130,700 |
| Apr 2025 | Industrial Research Assistance Program – Contributions to FirmsNational Research Council Canada | In Vivo Validation of Fusogenix Formulations Optimized for Delivery of Genetic Medicines to the Trabecular Meshwork of the EyeContribution | $250,000 |
| Feb 2025 | SIF Stream2- GrowthInnovation, Science and Economic Development Canada | Innovation and Biomanufacturing Centre projectOther transfer payment | $62,000,000 |
| Nov 2024 | Industrial Research Assistance Program – Contributions to FirmsNational Research Council Canada | MNC Collab - FOCUS2024 - Fusogenix Formulation Development for Safe and Potent Delivery of Nucleic Acid Cargoes in the EyeContribution | $75,000 |
| Oct 2023 | Canadian International Innovation Program (CIIP)Global Affairs Canada | CIIP PDA – Entos Pharmaceuticals Inc. – 2023-24Contribution | $7,802 |
| Sep 2022 | Industrial Research Assistance Program – Contributions to FirmsNational Research Council Canada | COVID-19 Vaccine: Phase 3 Clinical Trial of DNA-Based Vaccine Booster Covigenix VAX-001-1cContribution | $10,000,000 |
| Nov 2021 | Industrial Research Assistance Program – Contributions to FirmsNational Research Council Canada | COVID-19 Vaccine: Phase 2 clinical trial of DNA-based vaccine Covigenix VAX-001Contribution | $5,200,000 |
| Sep 2020 | Industrial Research Assistance Program – Contributions to FirmsNational Research Council Canada | COVID-19 Vaccine: Phase 1 clinical trial of DNA-based vaccine Covigenix VAX-001Contribution | $10,000,000 |
| May 2020 | Industrial Research Assistance Program – Contributions to FirmsNational Research Council Canada | COVID-19 Response: Rapid Prototyping and Deployment of a Fusogenix Vaccine and Immuno-therapeutic against COVID-19Contribution | $100,000 |
| Oct 2018 | Industrial Research Assistance Program – Contributions to FirmsNational Research Council Canada | Towards Single-Step manufacturing of LNP Gene TherapyContribution | $128,600 |
| Dec 2017 | Program not namedNational Research Council Canada | Contribution | $27,000 |
| Nov 2017 | Program not namedNational Research Council Canada | Contribution | $27,000 |
| Oct 2016 | Program not namedNational Research Council Canada | Contribution | $96,000 |